DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn Young Jeong | - |
dc.contributor.author | Pureum Lee | - |
dc.contributor.author | Moo-Seung Lee | - |
dc.contributor.author | Doo-Jin Kim | - |
dc.date.accessioned | 2023-05-15T16:33:11Z | - |
dc.date.available | 2023-05-15T16:33:11Z | - |
dc.date.issued | 2023 | - |
dc.identifier.issn | 1598-2629 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/31731 | - |
dc.description.abstract | Endemic human coronaviruses (HCoVs) have been evidenced to be cross-reactive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although a correlation exists between the immunological memory to HCoVs and coronavirus disease 2019 (COVID-19) severity, there is little experimental evidence for the effects of HCoV memory on the efficacy of COVID-19 vaccines. Here, we investigated the Ag-specific immune response to COVID-19 vaccines in the presence or absence of immunological memory against HCoV spike Ags in a mouse model. Pre-existing immunity against HCoV did not affect the COVID-19 vaccine-mediated humoral response with regard to Ag-specific total IgG and neutralizing Ab levels. The specific T cell response to the COVID-19 vaccine Ag was also unaltered, regardless of pre-exposure to HCoV spike Ags. Taken together, our data suggest that COVID-19 vaccines elicit comparable immunity regardless of immunological memory to spike of endemic HCoVs in a mouse model. | - |
dc.publisher | Korea Soc-Assoc-Inst | - |
dc.title | Pre-existing immunity to endemic human coronaviruses does not affect the immune response to SARS-CoV-2 spike in a murine vaccination model | - |
dc.title.alternative | Pre-existing immunity to endemic human coronaviruses does not affect the immune response to SARS-CoV-2 spike in a murine vaccination model | - |
dc.type | Article | - |
dc.citation.title | Immune Network | - |
dc.citation.number | 2 | - |
dc.citation.endPage | e19 | - |
dc.citation.startPage | e19 | - |
dc.citation.volume | 23 | - |
dc.contributor.affiliatedAuthor | Ahn Young Jeong | - |
dc.contributor.affiliatedAuthor | Pureum Lee | - |
dc.contributor.affiliatedAuthor | Moo-Seung Lee | - |
dc.contributor.affiliatedAuthor | Doo-Jin Kim | - |
dc.contributor.alternativeName | 정안영 | - |
dc.contributor.alternativeName | 이푸름 | - |
dc.contributor.alternativeName | 이무승 | - |
dc.contributor.alternativeName | 김두진 | - |
dc.identifier.bibliographicCitation | Immune Network, vol. 23, no. 2, pp. e19-e19 | - |
dc.identifier.doi | 10.4110/in.2023.23.e19 | - |
dc.subject.keyword | Human coronavirus (HCoV) | - |
dc.subject.keyword | Pre-existing immunity | - |
dc.subject.keyword | SARS-CoV-2 | - |
dc.subject.keyword | COVID-19 vaccine | - |
dc.subject.keyword | Cross-reactivity | - |
dc.subject.local | SARS-CoV-2 | - |
dc.subject.local | SARS-Cov-2 | - |
dc.subject.local | COVID-19 vaccine | - |
dc.subject.local | Covid19 vaccine | - |
dc.subject.local | Cross-reactivity | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.